Clinical outcome assessments in Duchenne muscular dystrophy and spinal muscular atrophy: past, present and future

Area of Science:

• Pediatric Neurology
• Rehabilitation Medicine
• Clinical Outcome Assessment

Background:

• Neuromuscular disorders significantly impact pediatric motor development.
• Standardized assessment tools are crucial for tracking disease progression and treatment efficacy.
• Existing scales have undergone substantial evolution over time.

Purpose of the Study:

• To provide a historical overview of motor development scales in pediatric neuromuscular disorders.
• To update on the advancements of scales used for spinal muscular atrophy and Duchenne muscular dystrophy.
• To explore the future trajectory of Clinical Outcome Assessments in this field.

Main Methods:

• Literature review of historical and contemporary scales.
• Analysis of scale development and validation processes.
• Focus on scales relevant to spinal muscular atrophy and Duchenne muscular dystrophy.

Main Results:

• Significant evolution in the sophistication and application of pediatric motor development scales.
• Identification of key advancements in scales for spinal muscular atrophy and Duchenne muscular dystrophy.
• Highlighting the collaborative efforts driving the development of outcome measures.

Conclusions:

• The field of pediatric neuromuscular disorder assessment has seen considerable progress.
• Continued refinement and collaboration are essential for developing robust Clinical Outcome Assessments.
• Future directions point towards more comprehensive and patient-centered outcome measures.